Balchem Corp 2017 Q2 Institutional Investor Sentiment Better Than Expected

December 16, 2017 - By Henry Gaston

 Balchem Corp  2017 Q2 Institutional Investor Sentiment  Better Than Expected

Sentiment for Balchem Corp (NASDAQ:BCPC)

Balchem Corp (NASDAQ:BCPC) institutional sentiment decreased to 1.14 in Q2 2017. Its down -0.02, from 1.16 in 2017Q1. The ratio has dropped, as 87 funds started new and increased holdings, while 76 trimmed and sold holdings in Balchem Corp. The funds in our partner’s database now possess: 26.48 million shares, down from 27.08 million shares in 2017Q1. Also, the number of funds holding Balchem Corp in their top 10 holdings decreased from 1 to 0 for a decrease of 1. Sold All: 20 Reduced: 56 Increased: 63 New Position: 24.

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, and medical sterilization industries in the United States and internationally. The company has market cap of $2.68 billion. The companyÂ’s Human Nutrition & Health segment offers creamer systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, chocolate systems, ice cream bases and variegates, cereals, grain based snacks, and cereal based ingredients; microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. It has a 42.36 P/E ratio. The Company’s Animal Nutrition & Health segment provides microencapsulated products that enhance health and milk production in ruminant animals; chelation technology, which provides enhanced nutrient absorption for species; and choline chloride, an essential nutrient for monogastric animal health.

The stock increased 3.62% or $2.93 during the last trading session, reaching $83.87. About 488,380 shares traded or 502.92% up from the average. Balchem Corporation (NASDAQ:BCPC) has risen 37.77% since December 16, 2016 and is uptrending. It has outperformed by 21.07% the S&P500.

Brown Capital Management Llc holds 3.46% of its portfolio in Balchem Corporation for 3.63 million shares. Capital Investment Services Of America Inc. owns 126,279 shares or 1.69% of their US portfolio. Moreover, Bard Associates Inc has 1.58% invested in the company for 44,738 shares. The Minnesota-based Summit Creek Advisors Llc has invested 1.52% in the stock. Conestoga Capital Advisors Llc, a Pennsylvania-based fund reported 358,044 shares.#img1#

Balchem Corporation (NASDAQ:BCPC) Ratings Coverage

Ratings analysis reveals 0 of Balchem’s analysts are positive. Out of 2 Wall Street analysts rating Balchem, 0 give it “Buy”, 1 “Sell” rating, while 1 recommend “Hold”. The lowest target is $6000 while the high is $60. The stock’s average target of $60 is -28.46% below today’s ($83.87) share price. BCPC was included in 3 notes of analysts from March 8, 2016. Pivotal Research downgraded the shares of BCPC in report on Friday, November 4 to “Sell” rating. Pivotal Research maintained the shares of BCPC in report on Friday, August 4 with “Sell” rating. The firm has “Neutral” rating by Sidoti given on Tuesday, March 8.

More recent Balchem Corporation (NASDAQ:BCPC) news were published by: which released: “Health Products Drive Balchem Corporation’s Growth” on March 01, 2017. Also published the news titled: “Form 4 BALCHEM CORP For: Dec 14 Filed by: COOMBS PAUL D” on December 15, 2017.‘s news article titled: “Balchem Corporation Acquires Innovative Food Processors, Inc.” with publication date: June 02, 2017 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.